Evidence map›Paper›PMID 40857415›Full record

ArticleAnnals of the Child Neurology Society2025

Increased Extra-Axial Cerebrospinal Fluid Volume in Children with Angelman Syndrome: Links to Sleep Problems and Seizures.

Zumin Chen, Dea Garic, Yinuo Xu, Rachel G Smith, Leigh Anne H Weisenfeld, Sun Hyung Kim, Martin A Styner, Joseph Piven, Benjamin D Philpot, Heather C Hazlett and 1 more

Abstract read
In one paragraph

Article in Annals of the Child Neurology Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zumin ChenCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.ORCID 0009-0000-4686-4830
Dea GaricCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.ORCID 0000-0003-3595-4210
Yinuo XuCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Rachel G SmithCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Leigh Anne H WeisenfeldCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Sun Hyung KimDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Martin A StynerDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Joseph PivenCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Benjamin D PhilpotCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.
Heather C HazlettCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.ORCID 0000-0001-9166-1434
Mark D ShenCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, NC, USA.ORCID 0000-0002-1190-7981

Funding

Preclinical CoreP50HD103573 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mark D Shen · 2020 to 2026
$9.7M
Postdoctoral Research in Neurodevelopmental DisordersT32HD040127 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENJAMIN D PHILPOT, Mark D Shen · 2001 to 2026
$8.5M
Longitudinal MRI Study of Brain Development in Fragile XR01MH064708 · NIMH · STANFORD UNIVERSITY · PI PIVEN, JOSEPH, REISS, ALLAN L · 2002 to 2016
$8.1M
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical TrialsR01HD093771 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAZLETT, HEATHER CODY, PHILPOT, BENJAMIN D · 2018 to 2022
$3.0M
Small Molecule Therapeutic Discovery for Angelman SyndromeR01NS131615 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jeffrey Aube, BENJAMIN D PHILPOT · 2023 to 2026
$2.3M
Investigating UBE3A as a driver gene in Duplication 15q syndromeR01NS129914 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENJAMIN D PHILPOT · 2023 to 2026
$1.6M
The Role of CSF Dynamics in Infant Brain and Behavioral Development in Down Syndrome and Related Neurodevelopmental DisordersK01HD109445 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Dea Garic · 2022 to 2026
$739k
White Matter Fiber Tract Pathology in a Genetically-Defined Neurodevelopmental DisorderR56NS097831 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAZLETT, HEATHER CODY, PHILPOT, BENJAMIN D · 2017 to 2017
$544k
NICHD NIH HHS K01 HD109445NICHD NIH HHS P50 HD103573NICHD NIH HHS R01 HD093771NICHD NIH HHS T32 HD040127NIMH NIH HHS R01 MH064708NINDS NIH HHS R01 NS129914NINDS NIH HHS R01 NS131615NINDS NIH HHS R56 NS097831
6 · The paper itself

Abstract

Background: Previous studies demonstrated that children with autism have enlarged volumes of extra-axial cerebrospinal fluid (EA-CSF) and increased ratio of EA-CSF to brain volume, indicating that EA-CSF is disproportionally increased beyond macrocephaly often observed in autism. It is unknown whether EA-CSF is disproportionally enlarged in Angelman syndrome (AS), which shares phenotypic features with autism (sleep problems, seizures) but is characterized by microcephaly. This study examined EA-CSF and total cerebral volume (TCV) in AS children compared to neurotypical (NT) controls to test whether EA-CSF is disproportionally enlarged and is associated with sleep problems and seizures. Methods: MRI scans were acquired in n=29 AS (M[SD]=6.95±2.83 years) and n=27 NT children (M[SD]=7.96±2.24). EA-CSF and TCV were compared using ANCOVA, controlling for age, sex, and group interactions. In AS, associations between EA-CSF, sleep quality, and seizure severity were evaluated by linear regression. Results: Children with AS had 22% smaller TCV ( Conclusion: Children with AS have disproportionally higher EA-CSF volume than would be predicted by their smaller brain size. EA-CSF was associated with sleep problems and seizures, which impact quality of life and are target endpoints of current AS clinical trials. Excessive CSF suggests that CSF circulation might be perturbed in AS, which could have implications for brain waste clearance, as well as impact the biodistribution of AS therapies delivered via CSF.

Indexed as

Angelman syndromeCerebrospinal fluidGlymphatic systemneurodevelopmental disordersSeizuresSleep

Identifiers

PMID40857415
PMCPMC12356226

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.